持有 爱博医疗(688050)的基金 |
报告期:2022-06-30 |
序号 |
基金代码 |
基金简称 |
持仓市值(元) |
持仓数量(股) |
占基金净值比例(%) |
1 | 003096 | 中欧医疗健康混合C | 629,649,557.60 | 2,808,428.00 | 0.89 |
2 | 003095 | 中欧医疗健康混合A | 629,649,557.60 | 2,808,428.00 | 0.89 |
3 | 110023 | 易方达医疗保健行业混合 | 178,597,944.20 | 796,601.00 | 4.85 |
4 | 512170 | 华宝中证医疗ETF | 175,486,496.60 | 782,723.00 | 1.20 |
5 | 000452 | 南方医药保健灵活配置混合 | 156,111,132.60 | 696,303.00 | 4.68 |
6 | 506003 | 富国科创板两年定期开放混合 | 117,007,289.60 | 521,888.00 | 4.56 |
7 | 000751 | 嘉实新兴产业股票 | 84,172,302.80 | 375,434.00 | 0.95 |
8 | 002132 | 广发鑫享混合 | 76,232,484.00 | 340,020.00 | 0.99 |
9 | 009714 | 华安聚优精选混合 | 73,607,774.60 | 328,313.00 | 0.94 |
10 | 001822 | 华商智能生活混合 | 67,247,444.80 | 299,944.00 | 2.39 |
11 | 470006 | 汇添富医药保健混合A | 65,203,189.20 | 290,826.00 | 1.07 |
12 | 003230 | 创金合信医疗保健股票A | 64,842,227.20 | 289,216.00 | 8.05 |
13 | 003231 | 创金合信医疗保健股票C | 64,842,227.20 | 289,216.00 | 8.05 |
14 | 008934 | 大成科技消费股票A | 64,668,920.60 | 288,443.00 | 4.26 |
15 | 008935 | 大成科技消费股票C | 64,668,920.60 | 288,443.00 | 4.26 |
16 | 009795 | 嘉实远见精选两年持有期混合 | 63,681,992.20 | 284,041.00 | 0.90 |
17 | 010187 | 嘉实核心成长混合C | 60,073,044.80 | 267,944.00 | 0.79 |
18 | 010186 | 嘉实核心成长混合A | 60,073,044.80 | 267,944.00 | 0.79 |
19 | 005304 | 嘉实医药健康股票C | 47,892,707.20 | 213,616.00 | 2.96 |
20 | 005303 | 嘉实医药健康股票A | 47,892,707.20 | 213,616.00 | 2.96 |
21 | 010388 | 易方达医药生物股票C | 47,653,261.60 | 212,548.00 | 1.98 |
22 | 010387 | 易方达医药生物股票A | 47,653,261.60 | 212,548.00 | 1.98 |
23 | 009264 | 泓德瑞兴三年持有期混合 | 47,650,347.00 | 212,535.00 | 0.59 |
24 | 000711 | 嘉实医疗保健股票 | 44,017,634.40 | 196,332.00 | 3.14 |
25 | 000595 | 嘉实泰和混合 | 43,848,139.20 | 195,576.00 | 0.94 |
26 | 070002 | 嘉实增长混合 | 41,722,499.00 | 186,095.00 | 1.38 |
27 | 519171 | 浦银安盛医疗健康混合 | 40,164,981.60 | 179,148.00 | 2.94 |
28 | 506002 | 易方达科创板两年定期开放混合 | 37,741,603.80 | 168,339.00 | 1.20 |
29 | 002959 | 汇添富盈泰混合 | 36,791,220.00 | 164,100.00 | 4.44 |
30 | 001766 | 上投摩根医疗健康股票 | 34,362,237.20 | 153,266.00 | 3.30 |
31 | 161017 | 富国中证500指数增强(LOF) | 29,694,841.60 | 132,448.00 | 0.37 |
32 | 010550 | 华商双擎领航混合 | 29,236,801.00 | 130,405.00 | 2.13 |
33 | 010585 | 创金合信医药消费股票A | 27,075,961.40 | 120,767.00 | 6.16 |
34 | 010586 | 创金合信医药消费股票C | 27,075,961.40 | 120,767.00 | 6.16 |
35 | 002669 | 华商万众创新混合 | 26,728,451.40 | 119,217.00 | 1.88 |
36 | 399011 | 中海医疗保健主题股票 | 25,646,013.80 | 114,389.00 | 2.49 |
37 | 000654 | 华商新锐产业混合 | 23,936,488.80 | 106,764.00 | 1.80 |
38 | 009137 | 嘉实瑞和两年持有期混合 | 23,140,130.40 | 103,212.00 | 0.98 |
39 | 000021 | 华夏优势增长混合 | 23,083,183.60 | 102,958.00 | 0.36 |
40 | 502056 | 广发中证医疗指数(LOF)A | 21,617,812.40 | 96,422.00 | 1.14 |
41 | 009881 | 广发中证医疗指数(LOF)C | 21,617,812.40 | 96,422.00 | 1.14 |
42 | 161039 | 富国中证1000指数增强(LOF) | 20,925,931.20 | 93,336.00 | 0.73 |
43 | 001933 | 华商新兴活力混合 | 20,178,000.00 | 90,000.00 | 2.33 |
44 | 206003 | 鹏华信用增利A | 20,104,910.80 | 89,674.00 | 0.38 |
45 | 206004 | 鹏华信用增利B | 20,104,910.80 | 89,674.00 | 0.38 |
46 | 010439 | 汇添富稳健汇盈一年持有混合 | 19,744,845.60 | 88,068.00 | 0.89 |
47 | 001898 | 易方达大健康主题混合 | 19,544,186.60 | 87,173.00 | 4.51 |
48 | 000338 | 鹏华双债保利债券 | 18,681,465.00 | 83,325.00 | 0.19 |
49 | 630001 | 华商领先企业混合 | 18,215,129.00 | 81,245.00 | 1.95 |
50 | 005643 | 鹏扬景升混合C | 18,015,815.20 | 80,356.00 | 3.79 |
51 | 005642 | 鹏扬景升混合A | 18,015,815.20 | 80,356.00 | 3.79 |
52 | 001915 | 宝盈医疗健康沪港深股票 | 17,896,540.80 | 79,824.00 | 2.94 |
53 | 000143 | 鹏华双债加利债券 | 15,359,717.80 | 68,509.00 | 0.19 |
54 | 001551 | 天弘中证医药100指数C | 15,197,397.00 | 67,785.00 | 0.98 |
55 | 001550 | 天弘中证医药100指数A | 15,197,397.00 | 67,785.00 | 0.98 |
56 | 006608 | 泓德研究优选混合 | 15,069,154.60 | 67,213.00 | 0.69 |
57 | 005665 | 鹏扬景欣混合C | 14,090,073.20 | 62,846.00 | 1.32 |
58 | 005664 | 鹏扬景欣混合A | 14,090,073.20 | 62,846.00 | 1.32 |
59 | 008359 | 华安医疗创新混合 | 13,332,725.60 | 59,468.00 | 1.17 |
60 | 006229 | 中欧医疗创新股票C | 13,035,884.80 | 58,144.00 | 0.10 |
61 | 006228 | 中欧医疗创新股票A | 13,035,884.80 | 58,144.00 | 0.10 |
62 | 001796 | 汇添富安鑫智选混合A | 12,902,261.60 | 57,548.00 | 4.04 |
63 | 002158 | 汇添富安鑫智选混合C | 12,902,261.60 | 57,548.00 | 4.04 |
64 | 159938 | 广发中证全指医药卫生ETF | 12,497,356.40 | 55,742.00 | 0.42 |
65 | 003516 | 国泰融安多策略灵活配置混合 |